Logo image
Thrombocytosis as a prognostic marker in gastrointestinal cancers
Journal article

Thrombocytosis as a prognostic marker in gastrointestinal cancers

World journal of gastrointestinal oncology, Vol.6(2), pp.34-40
02/15/2014
DOI: 10.4251/wjgo.v6.i2.34
PMCID: PMC3926972
PMID: 24567794

View Online

Abstract

Thrombocytosis is an adverse prognostic factor in many types of cancer. These include breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung cancers. In gastrointestinal cancers of various locations and histologic types, thrombocytosis has been reported in general to be associated with adverse clinical outcomes. Platelet count measurement is well standardized and available in every clinical laboratory, making its use as a prognostic marker practical. This paper will discuss the data on the prognostic value of thrombocytosis in gastrointestinal cancers as well as pathogenic aspects of the association that strengthen the case for its use in clinical prognostication. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
Gastroenterology & Hepatology Life Sciences & Biomedicine Oncology Science & Technology

Details

Logo image